Protein palmitoylation by a family of DHHC protein S-acyltransferases

被引:354
作者
Mitchell, David A.
Vasudevan, Anant
Linder, Maurine E.
Deschenes, Robert J. [1 ]
机构
[1] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
关键词
fatty acylation; cysteine rich domain; palmitoyl-coenzymeA;
D O I
10.1194/jlr.R600007-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein palmitoylation refers to the posttranslational addition of a 16 carbon fatty acid to the side chain of cysteine, forming a thioester linkage. This acyl modification is readily reversible, providing a potential regulatory mechanism to mediate protein-membrane interactions and subcellular trafficking of proteins. The mechanism that underlies the transfer of palmitate or other long-chain fatty acids to protein was uncovered through genetic screens in yeast. Two related S-palmitoyltransferases were discovered. Erf2 palmitoylates yeast Ras proteins, whereas Akr1 modifies the yeast casein kinase, Yck2. Erf2 and Akr1 share a common sequence referred to as a DHHC(aspartate-histidine-histidine-cysteine) domain. Numerous genes encoding DHHC domain proteins are found in all eukaryotic genome databases. Mounting evidence is consistent with this signature motif playing a direct role in protein acyltransferase ( PAT) reactions, although many questions remain. This review presents the genetic and biochemical evidence for the PAT activity of DHHC proteins and discusses the mechanism of protein-mediated palmitoylation.
引用
收藏
页码:1118 / 1127
页数:10
相关论文
共 74 条
[1]   Plasma membrane localization of the Yck2p yeast casein kinase 1 isoform requires the C-terminal extension and secretory pathway function [J].
Babu, P ;
Bryan, JD ;
Panek, HR ;
Jordan, SL ;
Forbrich, BM ;
Kelley, SC ;
Colvin, RT ;
Robinson, LC .
JOURNAL OF CELL SCIENCE, 2002, 115 (24) :4957-4968
[2]  
Bartuccelli M. V., 1999, Nonlinear Phenomena in Complex Systems, V2, P19
[3]   Farnesyl transferase inhibitors [J].
Basso, AD ;
Kirschmeier, P ;
Bishop, WR .
JOURNAL OF LIPID RESEARCH, 2006, 47 (01) :15-31
[4]  
BHARADWAJ M, 1995, J NEUROCHEM, V65, P1805
[5]   Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs [J].
Bhatnagar, RS ;
Fütterer, K ;
Farazi, TA ;
Korolev, S ;
Murray, CL ;
Jackson-Machelski, E ;
Gokel, GW ;
Gordon, JI ;
Waksman, G .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (12) :1091-1097
[6]   Variations of the C2H2 zinc finger motif in the yeast genome and classification of yeast zinc finger proteins [J].
Bohm, S ;
Frishman, D ;
Mewes, HW .
NUCLEIC ACIDS RESEARCH, 1997, 25 (12) :2464-2469
[7]   Modulation of Ras and a-factor function by carboxyl-terminal proteolysis [J].
Boyartchuk, VL ;
Ashby, MN ;
Rine, J .
SCIENCE, 1997, 275 (5307) :1796-1800
[8]  
Boyartchuk VL, 1998, GENETICS, V150, P95
[9]   P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID [J].
CASEY, PJ ;
SOLSKI, PA ;
DER, CJ ;
BUSS, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8323-8327
[10]  
CASEY PJ, 1992, J LIPID RES, V33, P1731